Mobile Health Intervention to Increase HIV Testing and Linkage to Care
NCT ID: NCT05484895
Last Updated: 2025-11-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1800 participants
INTERVENTIONAL
2021-12-15
2024-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
mHealth and HIV Self-testing
NCT03569462
MHealth Intervention of HIV and STDs Partner Notification for MSM
NCT04349748
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
NCT03984136
A Mobile Intervention to Improve Uptake of PrEP for Southern Black MSM
NCT03308097
Development of an HIV Self-testing Intervention
NCT02999243
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WeTest-WeLink intervention
Participants will have access to "WeTest-WeLink" application on the WeChat platform, which provides multi-media contents on HIV-related health information, online self-assessments, linkage to providers, data reports, and personal stories, in addition to two-way communication with non-governmental organizations (NGOs), and free, additional HST.
WeTest-WeLink
"WeTest-WeLink" application on the WeChat platform provides videos on HIV self-testing and linkage to care; informational articles on HIV, sexually transmitted infections (STI), testing, antiviral treatment (ART), and care; online behavioral self-assessments; linkage to providers; local data reports; stories about coping, wellness, and social support; two-way communication with NGO; and free, additional HST.
Control
Participants will receive contact information to local NGO to request basic information or receive emergency referrals; have access to "standard" WeChat group; and have free, additional HST.
Control condition
Contact information of local NGO for emergency referrals; free additional HST.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WeTest-WeLink
"WeTest-WeLink" application on the WeChat platform provides videos on HIV self-testing and linkage to care; informational articles on HIV, sexually transmitted infections (STI), testing, antiviral treatment (ART), and care; online behavioral self-assessments; linkage to providers; local data reports; stories about coping, wellness, and social support; two-way communication with NGO; and free, additional HST.
Control condition
Contact information of local NGO for emergency referrals; free additional HST.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chinese
* Cis-gender male
* Condomless anal sex with another man in the past 6 months
* Resident in the study location for at least 6 months and no desire to relocate during the study period
* In possession of a mobile "smart" phone with capability to download and use WeChat
* HIV-negative (verified through HIV self-test at enrollment)
* Able to give informed consent
Exclusion Criteria
* Self-report coercion to participate
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anhui Medical University
OTHER
Rutgers University
OTHER
University of Arkansas
OTHER
National Institute of Mental Health (NIMH)
NIH
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Don Operario
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Don Operario, PhD
Role: PRINCIPAL_INVESTIGATOR
Emory University
Cui Yang, PhD
Role: PRINCIPAL_INVESTIGATOR
Rutgers University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wuhan Centers for Disease Control and Prevention
Wuhan, Hubei, China
Suzhou Centers for Disease Control and Prevention
Suzhou, Jiangsu, China
Chengdu Tongle Health Counselling Service Center
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00005966
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.